Nivolumab effective treatment for malignant mesothelioma
E-Mail (Singapore--January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)-- Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer. Malignant mesothelioma is an intractable cancer, and no phase III trial has yet shown an improvement in overall survival following the standard first line chemotherapy doublet compr...
United Kingdom Gareth Griffiths Giorgio Scagliotti University Of Leicester University Of Southampton Eastern Cooperative Oncology Group
Source: eurekalert.org